Skip to content

Clinical trials

Completed Observational Glycogen Storage Disease Type II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Phase: Observational Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20072
20081
20101
20122
20131
20143
20154
20162
20171
20191
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company5
Duke University4
University of Florida3
Centre Hospitalier de Cayenne2
LMU Klinikum2
Amicus Therapeutics1
Centre Hospitalier Universitaire de Liege1
Hospitales Universitarios Virgen del Rocío1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
O & O Alpan LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II25
Glycogen Storage Disease2
Mucopolysaccharidosis I2
Muscular Diseases2
Adrenal Hyperplasia, Congenital1
Adrenoleukodystrophy1
Anaphylaxis1
Andersen Syndrome1
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.